ESSA Pharma(EPIX)

6.82 -0.16 -2.2923%

今开:6.94昨收:6.98
最高:6.94 最低:6.5
涨停价:0.0跌停价:0.0
总市值:3.01704163E8

ESSA Pharma的热门讨论

证券出售报告

ESSA Pharma(EPIX)04-06 03:05

$ESSA Pharma(EPIX)$ 144 Report of proposed sale of securities Accession Number: 0001974158-24-000020  Act: 33  Size: 7 KB 网页链接查看全文

持股变动声明

ESSA Pharma(EPIX)03-29 00:45

$ESSA Pharma(EPIX)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0000950172-24-000137  Size: 4 KB 网页链接查看全文

持股变动声明

ESSA Pharma(EPIX)03-29 00:45

$ESSA Pharma(EPIX)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0000950172-24-000135  Size: 4 KB 网页链接查看全文

持股变动声明

ESSA Pharma(EPIX)04-25 22:45

$ESSA Pharma(EPIX)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0000950172-24-000233  Size: 6 KB 网页链接查看全文

持股变动声明

ESSA Pharma(EPIX)03-06 07:55

$ESSA Pharma(EPIX)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001096906-24-000317  Size: 5 KB 网页链接查看全文

持股变动声明

ESSA Pharma(EPIX)03-29 00:35

$ESSA Pharma(EPIX)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0000950172-24-000130  Size: 5 KB 网页链接查看全文

持股变动声明

ESSA Pharma(EPIX)03-29 00:35

$ESSA Pharma(EPIX)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0000950172-24-000132  Size: 5 KB 网页链接查看全文

持股变动声明

ESSA Pharma(EPIX)03-29 00:45

$ESSA Pharma(EPIX)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0000950172-24-000138  Size: 4 KB 网页链接查看全文

当期报告

ESSA Pharma(EPIX)02-13 20:05

$ESSA Pharma(EPIX)$ 8-K Current report, items 2.02 and 9.01 Accession Number: 0001279569-24-000137  Act: 34  Size: 263 KB 网页链接查看全文

超过5%股东持股披露

ESSA Pharma(EPIX)02-14 20:15

$ESSA Pharma(EPIX)$ SC 13G Statement of acquisition of beneficial ownership by individuals Accession Number: 0000902664-24-001539  Act: 34  Size: 73 KB 网页链接查看全文

1 2 3

ESSA Pharma的最新讨论

产业链观察2023-04-12 20:03

#药闻简讯# 2023年4月12日,专注于开发治疗前列腺癌的新型疗法的临床阶段制药公司$Essa制药(EPIX)$ 今天宣布公司已经与$强生(JNJ)$ 杨森研究与发展有限公司("杨森")签订了一项临床试验支持协议("协议"),以便对ESSA的第一类N端域雄激素受体抑制剂EPI-7386与阿帕鲁胺的组合,以...查看全文

郁闷的鞋套-2022-10-31 20:44

$Essa制药(EPIX)$ 真会玩。。。。。[滴汗]
上周三,在宣布EPI-7386联合enzalutamide治疗mCRPC患者的1/2阶段数据后,ESSA公司股价大涨。
周一,EPIX盘前股价下跌26%,此前该公司宣布强生旗下的杨森研发公司将不再为其主要资产EPI-7386治疗前列腺癌的联合药物进行一期临床试验。
ESSA表...查看全文

妖股猎人| 电子烟消费税靴子落地 龙头企业连续大涨!哪些A股公司将受益?

港美情报站2022-10-27 21:44

电子烟消费税“靴子落地” 两大龙头企业连续大涨!
隔夜#美股# 表现一般,但中概股表现抢眼。我国电子烟龙头企业$雾芯科技(RLX)$ 以43%的涨幅,荣登妖股榜第三名。如果从三天前的低点算起,雾芯科技股价已经反弹逾60%。
在港股上市的思摩尔国际,虽然涨幅不如雾芯科技,但近三日也录得近30...查看全文

牛唐2021-08-24 14:57

辉瑞旗下的Breakthrough Growth Initiative向$延龄草治疗(TRIL)$ 投了2500万美元,还向$Essa制药(EPIX)$ 投了1000万美元,有些人认为后者也会被辉瑞收购,主打药物EPI-7386过往数据还是不错的。
之前辉瑞被授予EPI-7386临床计划中的查看某些临床数据的权利,但辉瑞及其附属公司承诺在提供“首...查看全文

Takeabreak2021-02-16 20:42

$ADC Therapeutics(ADCT)$ $万春医药(BYSI)$ 准备进入,都是重钙股;$Essa制药(EPIX)$ 已大涨好多,但后续潜力大查看全文

淘沙见金2021-02-13 00:50

新一代产品EPI-7386目前来看潜力巨大 $Essa制药(EPIX)$ 小药股的生命力真是顽强[很赞][很赞][很赞]查看全文

1 2

ESSA Pharma的公告

$Essa制药(EPIX)$ 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] Filed: 2019-10-28 AccNo: 0001279569-19-002177 Size: 39 KB 网页链接

$Essa制药(EPIX)$ 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] Filed: 2019-10-21 AccNo: 0001279569-19-002147 Size: 26 KB 网页链接

$Essa制药(EPIX)$ 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] Filed: 2019-10-18 AccNo: 0001279569-19-002139 Size: 38 KB 网页链接

$Essa制药(EPIX)$ F-3 - Registration statement by foreign private issuers Filed: 2019-10-09 AccNo: 0001144204-19-047713 Size: 472 KB 网页链接

$Essa制药(EPIX)$ 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] Filed: 2019-10-07 AccNo: 0001279569-19-002063 Size: 42 KB 网页链接

$Essa制药(EPIX)$ 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] Filed: 2019-09-30 AccNo: 0001279569-19-002001 Size: 39 KB 网页链接

$Essa制药(EPIX)$ 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] Filed: 2019-09-19 AccNo: 0001279569-19-001956 Size: 37 KB 网页链接

$Essa制药(EPIX)$ SC 13D/A [Amend] - General statement of acquisition of beneficial ownership Filed: 2019-09-06 AccNo: 0001193125-19-240118 Size: 166 KB 网页链接

$Essa制药(EPIX)$ 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] Filed: 2019-09-05 AccNo: 0001279569-19-001871 Size: 38 KB 网页链接

$Essa制药(EPIX)$ SC 13G - Statement of acquisition of beneficial ownership by individuals Filed: 2019-08-30 AccNo: 0001580642-19-004061 Size: 48 KB 网页链接

1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37